Macular Degeneration Channel
Topics & Medications
Quicklinks
Related Channels

Eylea Medication Information

Available by prescription only, EyleaTM (aflibercept) is licensed to help prevent or delay vision loss caused by neovascular "wet" macular degeneration in adults. It comes as an injection that is given in the eye. Your healthcare provider will administer the injection once every month for 12 weeks, and then every two months after that.
 
Before starting treatment with Eylea, make sure to review the medication's safety information with your healthcare provider. For example, you may not be able to use this medicine if you have certain allergies or if you are taking certain other medications. Also, people who have an eye infection or a history of a blood clot or stroke may not be able to safely use this product.
 
(For more information on this medication, click Eylea. This Web selection provides a complete overview on this product, including how it works, details on its safety and effectiveness, and possible side effects.)
 

Eylea Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.